Key facts
- This page summarizes Ralph Smalling's Form 4 filing for GENELUX Corp (GNLX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Dec 2024, 20:49.
Ralph Smalling - 18 Dec 2024 Form 4 Insider Report for GENELUX Corp (GNLX)
- Reporting relationship
- Head of Regulatory
- Issuer ticker
- GNLX
- Reported as of
- 18 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2024, 20:49:15 UTC
- Prior SEC filing
- 18 Dec 2024
- Next SEC filing
- 17 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sean Ryder, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ralph Smalling filed Form 4 for GENELUX Corp (GNLX) on 20 Dec 2024.
Change
- Previous filing in this sequence was filed on 18 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GNLX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +15,525
- Change %
- +95%
- Price
- $0.000000
- Shares after
- 31,847
- Date
- 18 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GNLX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +21,100
- Change %
- Price
- $0.000000
- Shares after
- 21,100
- Date
- 18 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,100
- Exercise price
- $2.29
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 25% of the RSUs vest on August 1, 2025, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
Footnote F2
25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.